Logo-aim
Arch Iran Med March. 2020;23(4): 255-264.
doi: 10.34172/aim.2020.07
  Abstract View: 2083
  PDF Download: 1422

Guideline

COVID19 Prevention & Care; A Cancer Specific Guideline

Ali Motlagh 1,2, Maisa Yamrali 3 * , Samira Azghandi 4, Payam Azadeh 2, Mohammad Vaezi 4, Farzaneh Ashrafi 5, Kazem Zendehdel 6, Hamidreza Mirzaei 2, Ali Basi 7, Afshin Rakhsha 2, Sharareh Seifi 8, Morteza Tabatabaeefar 2, Ahmad Elahi 9, Pouneh Pirjani 10, Leila Moadab Shoar 3, Faranak Nadarkhani 11, Mostafa Khoshabi 12, Massih Bahar 13, Fatemeh Esfahani 8,14, Hossein Fudazi 15, Farhad Samiei 16,17, Borna Farazmand 18, Azin Ahmari 19, Mojtaba Vand Rajabpour 6, Ghasem Janbabaei 4,20, Alireza Raisi 21,22, Afshin Ostovar 1,23, Reza Malekzadeh 1,24,25

1 National Cancer Control Secretariat, Ministry of Health and Medical Education, Tehran, Iran
2 Department of Radiation Oncology, Shaheed Beheshti Medical University, Tehran, Iran
3 Department of Radiation Oncology, Iran University of Medical Sciences, Tehran, Iran
4 Department of Hematology Oncology, Tehran University of Medical Sciences, Tehran, Iran
5 Department of Hematology Oncology, Isfahan University of Medical Sciences, Isfahan, Iran
6 Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
7 Department of Hematology Oncology, Iran University of Medical Sciences, Tehran, Iran
8 Department of Hematology Oncology, Shaheed Beheshti Medical University, Tehran, Iran
9 Department of Surgery, Alborz University of Medical Sciences, Karaj, Iran
10 Ala Cancer Prevention and Control Center (MACSA), Tehran, Iran
11 Standard and Clinical Guidelines Department, Ministry of Health and Medical Education, Tehran, Iran
12 Department of Geospatial Information System (GIS), Center of Excellence in GIS, K.N. Toosi Uni. of Technology, Tehran, Iran
13 Behnam Daheshpour Charity Organization, Tehran, Iran
14 Iranian Society of Medical Oncology and Hematology, Tehran, Iran
15 Iranian Society of Radiation Oncology, Tehran, Iran
16 Iranian Cancer Association, Tehran, Iran
17 Department of Radiation Oncology, Tehran University of Medical Sciences, Tehran, Iran
18 Department of Radiation Oncology, Mashhad University of Medical Sciences, Ghouchan, Iran
19 Department of Radiation Oncology, Arak University of Medical Sciences, Arak, Iran
20 Deputy of Curative Affairs, Ministry of Health and Medical Education, Tehran, Iran
21 Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
22 Deputy of Public Health, Ministry of Health and Medical Education, Tehran, Iran
23 Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran
24 Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
25 Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran
*Corresponding Author: Maisa Yamrali, MD; Department of Radiation Oncology, Iran University of Medical Sciences, Tehran, Iran. Email: maisa36@yahoo.com

Abstract

On March 11th 2020, the coronavirus outbreak was declared a pandemic by the WHO. One of the groups that is considered high risk in this pandemic are cancer patients as they are treated with a variety of immune system suppressor treatment modalities and this puts them in a great risk for infectious disease (including COVID-19). Therefore, cancer patients require higher level measures for preventing and treating infectious diseases. furthermore, cancer patients may bear additional risk due to the restriction of access to the routine diagnostic and therapeutic services during such epidemic. Since most of the attention of health systems is towards patients affected with COVID-19, the need for structured and unified approaches to COVID-19 prevention and care specific to cancer patients and cancer centers is felt more than ever. This article provides the recommendations and possible actions that should be considered by patients, their caregivers and families, physician, nurses, managers and staff of medical centers involved in cancer diagnosis and treatment. We pursued two major goals in our recommendations: first, limiting the exposure of cancer patients to medical environments and second, modifying the treatment modalities in a manner that reduces the probability of myelosuppression such as delaying elective diagnostic and therapeutic services, shortening the treatment course, or prolonging the interval between treatment courses.
Keywords: COVID-19, Cancer, Pandemic
Cite this article as: Motlagh A, Yamrali M, Azghandi S, Azadeh P, Vaezi M, Ashrafi F, et al. COVID19 prevention & care; a cancer specific guideline. Arch Iran Med. 2020;23(4):255–264. doi: 10.34172/aim.2020.07.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 2083

Your browser does not support the canvas element.


PDF Download: 1422

Your browser does not support the canvas element.

Submitted: 18 Mar 2020
Accepted: 21 Mar 2020
ePublished: 01 Apr 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)